Shiga toxin-associated hemolytic uremic syndrome
ORPHA:90038Clinical subtypeNot applicableAll ages
Фенотипы (HPO)33
Частый (30–79%)10
HP:0001873Thrombocytopenia
HP:0001919Acute kidney injury
HP:0001937Microangiopathic hemolytic anemia
HP:0002013Vomiting
HP:0002014Diarrhea
HP:0002027Abdominal pain
HP:0003259Elevated circulating creatinine concentration
HP:0005423Dysfunctional alternative complement pathway
HP:0008282Unconjugated hyperbilirubinemia
HP:0100519Anuria
Периодический (5–29%)16
HP:0000707Abnormality of the nervous system
HP:0000737Irritability
HP:0000822Hypertension
HP:0001250Seizure
HP:0001262Excessive daytime somnolence
HP:0001923Reticulocytosis
HP:0001944Dehydration
HP:0001974Leukocytosis
HP:0001981Schistocytosis
HP:0002900Hypokalemia
HP:0002902Hyponatremia
HP:0003641Hemoglobinuria
HP:0025085Bloody diarrhea
HP:0025435Increased circulating lactate dehydrogenase concentration
HP:0031368Intestinal perforation
HP:0100282Acute colitis
Очень редкий (1–4%)7
HP:0001259Coma
HP:0001658Myocardial infarction
HP:0001733Pancreatitis
HP:0002035Rectal prolapse
HP:0002576Intussusception
HP:0002586Peritonitis
HP:0012851Colonic stenosis
Эпидемиология2
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Annual incidence | 1-9 / 100 000 | 2.1 | United States | Value and class |
| Point prevalence | Unknown | — | Europe | Class only |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)